Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
Kjeld Schmiegelow(Rigshospitalet), Ester Zápotocká(University Hospital in Motol), Inge M. van der Sluis(Stichting Kinderoncologie Nederland), Roderick Skinner(Royal Victoria Infirmary), Gabriele Escherich(Universität Hamburg), Elizabeth A. Raetz(NYU Langone Health), Torben Stamm Mikkelsen(Aarhus University Hospital), Riitta Niinimäki(Oulu University Hospital), Sima Jeha(St. Jude Children's Research Hospital), Lewis B. Silverman(Boston Children's Hospital), Christina Halsey(University of Glasgow), Ruta Tuckuviene(Aalborg University Hospital), Anja Möricke(University of Lübeck), Motohiro Kato(National Center For Child Health and Development), Rachael Hough(University College London Hospitals NHS Foundation Trust), Caroline Piette(Centre hospitalier régional de la Citadelle), Andishe Attarbaschi(St Anna Children's Hospital), Der-Cherng Liang(Mackay Memorial Hospital), Maria Caterina Putti, Shlomit Barzilai(Schneider Children's Medical Center), Thomas Leth Frandsen(Rigshospitalet)
Cited by 268
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616